Literature DB >> 16859727

Inhibition of endogenous reverse transcription of human and nonhuman primate lentiviruses: potential for development of lentivirucides.

Elias G Argyris1, Geethanjali Dornadula, Giuseppe Nunnari, Edward Acheampong, Chune Zhang, Ketti Mehlman, Roger J Pomerantz, Hui Zhang.   

Abstract

In the current study, we extended our previous works on natural endogenous reverse transcription (NERT) and further examined its potential as a virucide molecular target in sexual transmission of primate lentiviruses. HIV-1 and SIV virions were pretreated with select nucleoside (NRTIs) and nonnucleoside RT inhibitors (NNRTIs), either alone or in combination with NERT-stimulating substances. The effects of these antiretrovirals on virion inactivation were analyzed in human T cell lines and primary cell cultures. Pretreatment of HIV-1 virions with physiologic NERT-stimulants and 3'-azido-3'-deoxythymidine 5'-triphosphate (AZT-TP) or nevirapine potently inactivated cell-free HIV-1 virions and resulted in strong inhibition of the viral infectivity. Pretreatment of chimeric SHIV-RT virions with NERT-stimulating cocktail and select antiretrovirals also resulted in virion inactivation and inhibition of viral infectivity in T cell lines. Our findings demonstrate the potential clinical utility of approaches based on inhibiting NERT in sexual transmission of HIV-1, through the development of effective anti-HIV-1 microbicides, such as NRTIs and NNRTIs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16859727      PMCID: PMC1626530          DOI: 10.1016/j.virol.2006.06.014

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  36 in total

1.  Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammation.

Authors:  R N Fichorova; F Zhou; V Ratnam; V Atanassova; S Jiang; N Strick; A R Neurath
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

2.  Natural endogenous reverse transcription of HIV type 1.

Authors:  H Zhang; G Dornadula; R J Pomerantz
Journal:  AIDS Res Hum Retroviruses       Date:  1998-04       Impact factor: 2.205

3.  HIV-1 virions produced from replicating peripheral blood lymphocytes are more infectious than those from nonproliferating macrophages due to higher levels of intravirion reverse transcripts: implications for pathogenesis and transmission.

Authors:  G Dornadula; H Zhang; S Shetty; R J Pomerantz
Journal:  Virology       Date:  1999-01-05       Impact factor: 3.616

4.  Amphipathic domains in the C terminus of the transmembrane protein (gp41) permeabilize HIV-1 virions: a molecular mechanism underlying natural endogenous reverse transcription.

Authors:  H Zhang; G Dornadula; P Alur; M A Laughlin; R J Pomerantz
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

5.  Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenviroments: an important stage for viral infection of nondividing cells.

Authors:  H Zhang; G Dornadula; R J Pomerantz
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

6.  SIV/HIV-1 hybrid virus expressing the reverse transcriptase gene of HIV-1 remains sensitive to HIV-1-specific reverse transcriptase inhibitors after passage in rhesus macaques.

Authors:  J Balzarini; E De Clercq; K Uberla
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-05-01

7.  Natural endogenous reverse transcription of simian immunodeficiency virus.

Authors:  G Dornadula; H Zhang; O Bagasra; R J Pomerantz
Journal:  Virology       Date:  1997-01-06       Impact factor: 3.616

8.  In vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques.

Authors:  C J Miller; M Marthas; J Greenier; D Lu; P J Dailey; Y Lu
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

9.  Kinetic analysis of intravirion reverse transcription in the blood plasma of human immunodeficiency virus type 1-infected individuals: direct assessment of resistance to reverse transcriptase inhibitors in vivo.

Authors:  H Zhang; G Dornadula; Y Wu; D Havlir; D D Richman; R J Pomerantz
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Preclinical studies on thiocarboxanilide UC-781 as a virucidal agent.

Authors:  J Balzarini; L Naesens; E Verbeken; M Laga; L Van Damme; M Parniak; L Van Mellaert; J Anné; E De Clercq
Journal:  AIDS       Date:  1998-07-09       Impact factor: 4.177

View more
  3 in total

1.  Anti HIV-1 virucidal activity of polyamide nucleic acid-membrane transducing peptide conjugates targeted to primer binding site of HIV-1 genome.

Authors:  Snehlata Tripathi; Binay Chaubey; Beverly E Barton; Virendra N Pandey
Journal:  Virology       Date:  2007-02-21       Impact factor: 3.616

2.  Mechanism of Deoxyguanosine Diphosphate Insertion by Human DNA Polymerase β.

Authors:  Fausto A Varela; Bret D Freudenthal
Journal:  Biochemistry       Date:  2021-01-21       Impact factor: 3.162

3.  Drug 9AA reactivates p21/Waf1 and Inhibits HIV-1 progeny formation.

Authors:  Weilin Wu; Kylene Kehn-Hall; Caitlin Pedati; Lynnsey Zweier; Iris Castro; Zachary Klase; Cynthia S Dowd; Larisa Dubrovsky; Michael Bukrinsky; Fatah Kashanchi
Journal:  Virol J       Date:  2008-03-18       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.